JP2023515620A5 - - Google Patents
Info
- Publication number
- JP2023515620A5 JP2023515620A5 JP2022552208A JP2022552208A JP2023515620A5 JP 2023515620 A5 JP2023515620 A5 JP 2023515620A5 JP 2022552208 A JP2022552208 A JP 2022552208A JP 2022552208 A JP2022552208 A JP 2022552208A JP 2023515620 A5 JP2023515620 A5 JP 2023515620A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- pharmaceutical composition
- nucleic acid
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026060544A JP2026108831A (ja) | 2020-02-28 | 2026-04-01 | スプライシングを調節するための化合物及び方法 |
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062983541P | 2020-02-28 | 2020-02-28 | |
| US62/983,541 | 2020-02-28 | ||
| US202063007333P | 2020-04-08 | 2020-04-08 | |
| US63/007,333 | 2020-04-08 | ||
| US202063040484P | 2020-06-17 | 2020-06-17 | |
| US63/040,484 | 2020-06-17 | ||
| US202063072790P | 2020-08-31 | 2020-08-31 | |
| US63/072,790 | 2020-08-31 | ||
| US202063126492P | 2020-12-16 | 2020-12-16 | |
| US63/126,492 | 2020-12-16 | ||
| PCT/US2021/020153 WO2021174164A1 (en) | 2020-02-28 | 2021-02-28 | Compounds and methods for modulating splicing |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026060544A Division JP2026108831A (ja) | 2020-02-28 | 2026-04-01 | スプライシングを調節するための化合物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023515620A JP2023515620A (ja) | 2023-04-13 |
| JP2023515620A5 true JP2023515620A5 (cg-RX-API-DMAC7.html) | 2025-08-22 |
| JP7847852B2 JP7847852B2 (ja) | 2026-04-20 |
Family
ID=75143749
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022552208A Active JP7847852B2 (ja) | 2020-02-28 | 2021-02-28 | スプライシングを調節するための化合物及び方法 |
| JP2022552209A Active JP7736700B2 (ja) | 2020-02-28 | 2021-02-28 | 複素環アミド及びスプライシングを調節するためのその使用 |
| JP2025142246A Pending JP2025172876A (ja) | 2020-02-28 | 2025-08-28 | 複素環アミド及びスプライシングを調節するためのその使用 |
| JP2026060544A Pending JP2026108831A (ja) | 2020-02-28 | 2026-04-01 | スプライシングを調節するための化合物及び方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022552209A Active JP7736700B2 (ja) | 2020-02-28 | 2021-02-28 | 複素環アミド及びスプライシングを調節するためのその使用 |
| JP2025142246A Pending JP2025172876A (ja) | 2020-02-28 | 2025-08-28 | 複素環アミド及びスプライシングを調節するためのその使用 |
| JP2026060544A Pending JP2026108831A (ja) | 2020-02-28 | 2026-04-01 | スプライシングを調節するための化合物及び方法 |
Country Status (15)
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4151627A1 (en) | 2017-06-05 | 2023-03-22 | PTC Therapeutics, Inc. | Compounds for treating huntington's disease |
| MX2020001425A (es) | 2017-08-04 | 2020-08-06 | Skyhawk Therapeutics Inc | Metodos y composiciones para modular el empalme. |
| WO2020163248A1 (en) | 2019-02-04 | 2020-08-13 | Skyhawk Therapeutics, Inc. | Methods and compositions for modulating splicing |
| WO2020163541A1 (en) | 2019-02-05 | 2020-08-13 | Skyhawk Therapeutics, Inc. | Methods and compositions for modulating splicing |
| JP7603594B2 (ja) | 2019-02-06 | 2024-12-20 | スカイホーク・セラピューティクス・インコーポレーテッド | スプライシングを調節するための方法および組成物 |
| CA3139821A1 (en) | 2019-05-13 | 2020-11-19 | Ptc Therapeutics, Inc. | Compounds for treating huntington's disease |
| IL297963A (en) | 2020-05-07 | 2023-01-01 | Adorx Therapeutics Ltd | Antagonists of the adenosine a2a receptor |
| WO2021231571A1 (en) | 2020-05-13 | 2021-11-18 | Chdi Foundation, Inc. | Htt modulators for treating huntington's disease |
| US12065427B2 (en) | 2021-04-29 | 2024-08-20 | Boehringer Ingelheim International Gmbh | Heterocyclic compounds capable of activating STING |
| IL311135A (en) | 2021-08-30 | 2024-04-01 | Remix Therapeutics Inc | Compounds and methods for modulating splicing |
| MX2024002554A (es) | 2021-08-30 | 2024-07-02 | Remix Therapeutics Inc | Compuestos y metodos para modular el empalme. |
| AU2022394333A1 (en) * | 2021-11-17 | 2024-06-27 | Chdi Foundation, Inc. | HTT modulators for treating Huntington’s disease |
| CA3249778A1 (en) * | 2022-06-15 | 2023-12-21 | Ptc Therapeutics, Inc. | HETEROCYCLIC AND HETEROARYL COMPOUNDS FOR THE TREATMENT OF HUNTINGTON'S DISEASE |
| WO2024086569A1 (en) | 2022-10-17 | 2024-04-25 | Vanderbilt University | Positive allosteric modulators of the muscarinic acetylcholine receptor m1 |
| WO2024086570A1 (en) | 2022-10-17 | 2024-04-25 | Vanderbilt University | Positive allosteric modulators of the muscarinic acetylcholine receptor m1 |
| TW202440080A (zh) * | 2023-03-01 | 2024-10-16 | 美商雷密克斯醫療公司 | 用於調節剪接之化合物及方法 |
| WO2024182788A1 (en) * | 2023-03-01 | 2024-09-06 | Remix Therapeutics Inc. | Compounds and methods for modulating splicing |
| TW202535379A (zh) * | 2024-01-26 | 2025-09-16 | 大陸商成都微芯藥業有限公司 | Usp1抑制劑及其製備方法和用途 |
| CN118166099B (zh) * | 2024-02-05 | 2024-10-22 | 北京大学深圳医院 | 检测hsa_circ_0014088的试剂在制备诊断口腔鳞状细胞癌的试剂盒中的应用 |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4809656B2 (ja) * | 2005-09-29 | 2011-11-09 | 富士フイルム株式会社 | ナフタロシアニン色素およびその製造方法 |
| US20070254894A1 (en) * | 2006-01-10 | 2007-11-01 | Kane John L Jr | Novel small molecules with selective cytotoxicity against human microvascular endothelial cell proliferation |
| TW200808325A (en) | 2006-07-06 | 2008-02-16 | Astrazeneca Ab | Novel compounds |
| ME02789B (me) * | 2006-08-08 | 2011-06-30 | Millennium Pharm Inc | Jedinjenja heteroarila korisna kao inhibitori e1 aktivirajućih enzima |
| WO2008040951A1 (en) | 2006-10-03 | 2008-04-10 | Astrazeneca Ab | Compounds |
| US20100029657A1 (en) | 2008-02-29 | 2010-02-04 | Wyeth | Bridged, Bicyclic Heterocyclic or Spiro Bicyclic Heterocyclic Derivatives of Pyrazolo[1, 5-A]Pyrimidines, Methods for Preparation and Uses Thereof |
| GB0807910D0 (en) * | 2008-04-30 | 2008-06-04 | Glaxo Group Ltd | Compounds |
| AU2009248774B2 (en) * | 2008-05-23 | 2012-05-31 | Novartis Ag | Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors |
| US20110288089A1 (en) | 2009-01-22 | 2011-11-24 | Syngenta Crop Protection Llc | Insecticidal compounds |
| EP2435421A1 (en) | 2009-05-29 | 2012-04-04 | Schering Corporation | Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis c |
| CN102020643A (zh) | 2009-09-22 | 2011-04-20 | 上海恒瑞医药有限公司 | 二氢喋啶酮类衍生物、其制备方法及其在医药上的应用 |
| TW201202230A (en) * | 2010-05-24 | 2012-01-16 | Mitsubishi Tanabe Pharma Corp | Novel quinazoline compound |
| JP5826261B2 (ja) * | 2010-06-28 | 2015-12-02 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung | 癌に対する使用のためのキナーゼ阻害剤としての2,4−ジアリール置換[1,8]ナフチリジン |
| JP2012028440A (ja) | 2010-07-21 | 2012-02-09 | Hitachi Kokusai Electric Inc | 基板処理装置及び半導体装置の製造方法 |
| EP3406252B1 (en) | 2012-02-10 | 2020-05-13 | PTC Therapeutics, Inc. | Compounds for treating spinal muscular atrophy |
| CN104271568B (zh) | 2012-05-09 | 2016-05-04 | 硕腾服务有限责任公司 | 作为抗寄生虫剂的氮杂环丁烷衍生物 |
| US8729263B2 (en) | 2012-08-13 | 2014-05-20 | Novartis Ag | 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions |
| EP2970312B1 (en) * | 2013-03-11 | 2017-11-15 | The Regents of The University of Michigan | Bet bromodomain inhibitors and therapeutic methods using the same |
| KR20140125061A (ko) * | 2013-04-18 | 2014-10-28 | (주)경인양행 | 유기발광 화합물 및 이를 포함하는 유기전계발광소자 |
| CA2913785C (en) | 2013-06-25 | 2021-08-31 | F. Hoffmann-La Roche Ag | Compounds for treating spinal muscular atrophy |
| MX375925B (es) | 2014-06-25 | 2025-03-07 | Hoffmann La Roche | Compuestos imidazo[1,2-a]pirazin-1-il-benzamida para tratar atrofia muscular espinal. |
| WO2016004254A1 (en) * | 2014-07-01 | 2016-01-07 | The Regents Of The University Of California | Combined modulation of ire1 |
| US9862701B2 (en) | 2014-09-25 | 2018-01-09 | Araxes Pharma Llc | Inhibitors of KRAS G12C mutant proteins |
| CN104341403B (zh) * | 2014-10-10 | 2016-06-22 | 山东盛华电子新材料有限公司 | 一种2,5-二杂环取代萘基噁烷衍生物及其制备方法 |
| NL2013636B1 (en) | 2014-10-15 | 2016-10-04 | Kraton Polymers Us Llc | An accelerator system, a composition comprisng a synthetic isoprene polymer and the accelerator system, and dipped goods made from the composition. |
| EP3256126B1 (en) | 2015-02-09 | 2024-03-27 | F. Hoffmann-La Roche AG | Compounds for the treatment of cancer |
| CN106220644B (zh) * | 2015-04-24 | 2020-07-31 | 广州再极医药科技有限公司 | 稠环嘧啶氨基衍生物﹑其制备方法、中间体、药物组合物及应用 |
| EP3310169B1 (en) | 2015-05-30 | 2023-05-17 | PTC Therapeutics, Inc. | Methods for modulating rna splicing |
| CA3119019C (en) | 2015-12-10 | 2024-06-11 | Ptc Therapeutics, Inc. | Compounds and methods for treating huntington's disease |
| WO2017147328A1 (en) * | 2016-02-23 | 2017-08-31 | Portola Pharmaceuticals, Inc. | Compounds for binding proprotein convertase subtilisin/kexin type 9 (pcsk9) |
| JP2019535789A (ja) | 2016-11-28 | 2019-12-12 | ピーティーシー セラピューティクス,インコーポレーテッド | Rnaスプライシングを調節する方法 |
| EP3573954A1 (en) * | 2017-01-26 | 2019-12-04 | Araxes Pharma LLC | Fused bicyclic benzoheteroaromatic compounds and methods of use thereof |
| EP4151627A1 (en) * | 2017-06-05 | 2023-03-22 | PTC Therapeutics, Inc. | Compounds for treating huntington's disease |
| CN111372611A (zh) | 2017-06-14 | 2020-07-03 | Ptc医疗公司 | 修饰rna剪接的方法 |
| MX2020001425A (es) | 2017-08-04 | 2020-08-06 | Skyhawk Therapeutics Inc | Metodos y composiciones para modular el empalme. |
| US20230152257A1 (en) | 2017-09-25 | 2023-05-18 | Skyhawk Therapeutics, Inc. | Methods and compositions for screening and identification of splicing |
| EP3697786B1 (en) * | 2017-10-18 | 2022-08-31 | Blueprint Medicines Corporation | Substituted pyrrolopyridines as inhibitors of activin receptor-like kinase |
| TW201942115A (zh) * | 2018-02-01 | 2019-11-01 | 美商輝瑞股份有限公司 | 作為抗癌藥之經取代的喹唑啉和吡啶並嘧啶衍生物 |
| JP2021521200A (ja) | 2018-04-10 | 2021-08-26 | スカイホーク・セラピューティクス・インコーポレーテッド | 癌の処置のための化合物 |
| IL279688B2 (en) | 2018-06-27 | 2025-01-01 | Ptc Therapeutics Inc | Heterocyclic and heteroaryl compounds for the treatment of Huntington's disease |
| WO2020004594A1 (ja) * | 2018-06-27 | 2020-01-02 | 株式会社リボルナバイオサイエンス | 脊髄性筋萎縮症の予防または治療剤 |
| TWI834690B (zh) * | 2018-07-18 | 2024-03-11 | 美商富曼西公司 | 用於防治無脊椎動物害蟲之異噁唑啉化合物 |
| CN109180690A (zh) * | 2018-10-15 | 2019-01-11 | 烟台显华化工科技有限公司 | 一类用作蓝色荧光材料的氮杂芳香化合物及其应用 |
| US12503467B2 (en) * | 2018-12-10 | 2025-12-23 | Ideaya Biosciences, Inc. | 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors |
| US20220081412A1 (en) * | 2018-12-20 | 2022-03-17 | The Regents Of The University Of Michigan | Quinolinyl-pyrazine-carboxamide compounds and uses thereof |
| KR20220012248A (ko) * | 2019-04-22 | 2022-02-03 | 베타 파머수티컬 컴퍼니 리미티드 | 퀴나졸린 화합물 및 이의 의약품에서의 응용 |
| WO2021007378A1 (en) * | 2019-07-11 | 2021-01-14 | Ptc Therapeutics, Inc. | Compounds for use in treating huntington's disease |
-
2021
- 2021-02-28 AU AU2021228284A patent/AU2021228284A1/en active Pending
- 2021-02-28 EP EP21713823.9A patent/EP4110464A1/en active Pending
- 2021-02-28 US US17/802,833 patent/US20240190879A1/en active Pending
- 2021-02-28 AU AU2021228767A patent/AU2021228767A1/en active Pending
- 2021-02-28 WO PCT/US2021/020153 patent/WO2021174164A1/en not_active Ceased
- 2021-02-28 JP JP2022552208A patent/JP7847852B2/ja active Active
- 2021-02-28 KR KR1020227033660A patent/KR20220159386A/ko not_active Ceased
- 2021-02-28 CA CA3169691A patent/CA3169691A1/en active Pending
- 2021-02-28 MX MX2022010684A patent/MX2022010684A/es unknown
- 2021-02-28 US US17/802,863 patent/US20240226098A1/en active Pending
- 2021-02-28 IL IL295956A patent/IL295956A/en unknown
- 2021-02-28 US US17/802,719 patent/US20230365566A1/en active Pending
- 2021-02-28 CA CA3169709A patent/CA3169709A1/en active Pending
- 2021-02-28 BR BR112022017210A patent/BR112022017210A2/pt unknown
- 2021-02-28 JP JP2022552209A patent/JP7736700B2/ja active Active
- 2021-02-28 EP EP21713822.1A patent/EP4110785A1/en active Pending
- 2021-02-28 BR BR112022017188A patent/BR112022017188A2/pt unknown
- 2021-02-28 CN CN202180031467.0A patent/CN115485025A/zh active Pending
- 2021-02-28 EP EP21713824.7A patent/EP4110459A1/en active Pending
- 2021-02-28 CR CR20210483A patent/CR20210483A/es unknown
- 2021-02-28 WO PCT/US2021/020154 patent/WO2021174165A1/en not_active Ceased
- 2021-02-28 WO PCT/US2021/020152 patent/WO2021174163A1/en not_active Ceased
- 2021-02-28 IL IL295957A patent/IL295957A/en unknown
- 2021-02-28 CN CN202180030671.0A patent/CN115515679A/zh active Pending
- 2021-02-28 MX MX2022010683A patent/MX2022010683A/es unknown
- 2021-02-28 KR KR1020227033663A patent/KR20220158238A/ko not_active Ceased
- 2021-02-28 CR CR20220484A patent/CR20220484A/es unknown
-
2022
- 2022-08-26 CL CL2022002342A patent/CL2022002342A1/es unknown
- 2022-08-26 CL CL2022002341A patent/CL2022002341A1/es unknown
- 2022-08-28 SA SA522440338A patent/SA522440338B1/ar unknown
- 2022-09-27 CO CONC2022/0013832A patent/CO2022013832A2/es unknown
- 2022-09-27 CO CONC2022/0013827A patent/CO2022013827A2/es unknown
-
2025
- 2025-08-28 JP JP2025142246A patent/JP2025172876A/ja active Pending
-
2026
- 2026-04-01 JP JP2026060544A patent/JP2026108831A/ja active Pending